About OrganOx
OrganOx is a company based in Oxford (United Kingdom) founded in 2008 by Peter Friend and Constantin Coussios was acquired by Terumo Medical in August 2025.. OrganOx has raised $45.42 million across 8 funding rounds from investors including University of Oxford, Oxford Technology and Terumo Medical. The company has 14 employees as of April 30, 2018. OrganOx offers products and services including metra. OrganOx operates in a competitive market with competitors including TransMedics, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
- Headquarter Oxford, United Kingdom
- Employees 14 as on 30 Apr, 2018
- Founders Peter Friend, Constantin Coussios
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Organox Limited
- Date of Incorporation 07 Apr, 2008
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
$1.36 M (USD)647as on Apr 30, 2018
-
Net Profit
$-5.32 M (USD)-40as on Apr 30, 2018
-
EBITDA
-
Total Equity Funding
$45.42 M (USD)
in 8 rounds
-
Latest Funding Round
-
Investors
University of Oxford
& 13 more
-
Employee Count
14
as on Apr 30, 2018
-
Acquired by
Terumo Medical
(Aug 23, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OrganOx
OrganOx offers a comprehensive portfolio of products and services, including metra. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for normothermic perfusion and preservation of donor livers.
Unlock access to complete
Unlock access to complete
Funding Insights of OrganOx
OrganOx has successfully raised a total of $45.42M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Last Round
-
First Round
First Round
(24 Dec 2008)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series D - OrganOx | Valuation | Health Quest Capital | |
| Jul, 2023 | Amount | Series D - OrganOx | Valuation | Lauxera Capital Partners |
|
| Jan, 2020 | Amount | Series D - OrganOx | Valuation | BGF |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OrganOx
OrganOx has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, Oxford Technology and Terumo Medical. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location | |
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on the healthcare sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OrganOx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OrganOx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Organox Comparisons
Competitors of OrganOx
OrganOx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of organ transplantation technology
|
|
| domain | founded_year | HQ Location |
Organ preservation and transport systems are developed for transplants.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a device for organ preservation
|
|
| domain | founded_year | HQ Location |
Multi-organ support systems for liver, lung, and kidney are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Organox
Frequently Asked Questions about OrganOx
When was OrganOx founded?
OrganOx was founded in 2008.
Where is OrganOx located?
OrganOx is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Who is the current CEO of OrganOx?
Craig Marshall is the current CEO of OrganOx.
Is OrganOx a funded company?
OrganOx is a funded company, having raised a total of $45.42M across 8 funding rounds to date. The company's 1st funding round was a Series D of $6.05M, raised on Dec 24, 2008.
How many employees does OrganOx have?
As of Apr 30, 2018, the latest employee count at OrganOx is 14.
What is the annual revenue of OrganOx?
Annual revenue of OrganOx is $1.36M as on Apr 30, 2018.
What does OrganOx do?
Founded in 2008 in Oxford, United Kingdom, OrganOx operates within the medical device sector for organ transplantation. Systems for warm preservation of harvested organs are developed, including the metra device designed for transport with extended battery life and self-regulating oxygen supply. Physiological conditions at 37C are maintained through perfusion with oxygen-carrying red cells, differing from traditional cold storage at 4C using non-physiological solutions.
Who are the top competitors of OrganOx?
OrganOx's top competitors include TransMedics, ADVITOS and Paragonix Technologies.
What products or services does OrganOx offer?
OrganOx offers metra.
Who are OrganOx's investors?
OrganOx has 14 investors. Key investors include University of Oxford, Oxford Technology, Terumo Medical, Oxford University Innovation, and Royal Society.
What is OrganOx's valuation?
The valuation of OrganOx is $74.7M as of Jan 2020.